Timber Hill’s Elevance Health ELV Stock Holding History

Timber Hill’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,096	Closed	-$900K	–	127
2018 Q1	$900K	Buy	+4,096	New	+$962K	0.14%	130
2017 Q2	–	Sell	-3,336	Closed	-$599K	–	1193
2017 Q1	$552K	Sell	3,336 -23,570	-88%	-$3.75M	﹤0.01%	1423
2016 Q4	$3.87M	Buy	26,906 +16,122	+149%	+$2.16M	0.02%	619
2016 Q3	$1.35M	Buy	+10,784	New	+$1.39M	0.01%	971
2015 Q3	–	Sell	-4,722	Closed	-$710K	–	2447
2015 Q2	$775K	Sell	4,722 -7,616	-62%	-$1.22M	﹤0.01%	1658
2015 Q1	$1.91M	Buy	+12,338	New	+$1.76M	0.01%	1066
2014 Q4	–	Sell	-22,027	Closed	-$2.72M	–	2554
2014 Q3	$2.63M	Buy	+22,027	New	+$2.53M	0.01%	962
2014 Q1	–	Sell	-6,673	Closed	-$604K	–	2771
2013 Q4	$617K	Sell	6,673 -927	-12%	-$82.4K	﹤0.01%	2176
2013 Q3	$635K	Buy	+7,600	New	+$651K	﹤0.01%	2268

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Timber Hill's ELV Position: Q2 2018 in Review

Timber Hill sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 4,096 shares — an estimated $900K sold.

Timber Hill first reported a position in ELV in Q3 2013 and held it in 9 quarters. The position peaked at $3.87M in Q4 2016. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Timber Hill reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 4,096 Elevance Health shares in Q2 2018, an estimated $900K.
Timber Hill first reported a position in Elevance Health in Q3 2013 and held it in 9 quarters.
Timber Hill's Elevance Health position peaked at $3.87M in Q4 2016.
935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.